Post-earnings recap
Reported
Mon, Aug 1, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Despite missing EPS expectations, Haemonetics' stock rose by 10.55%, likely driven by positive sentiment around management's focus on operational improvements. Investors may be optimistic about the company's long-term strategy, even in the face of short-term challenges.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.25 | N/A | -11.35% |
Management expressed a commitment to enhancing operational efficiency. They acknowledged current challenges but maintained confidence in their long-term strategy.
We are focused on improving our operational efficiency.
Our long-term strategy remains intact despite short-term challenges.